首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   97788篇
  免费   6699篇
  国内免费   295篇
耳鼻咽喉   1295篇
儿科学   2522篇
妇产科学   2201篇
基础医学   14446篇
口腔科学   2293篇
临床医学   9357篇
内科学   20947篇
皮肤病学   1365篇
神经病学   9189篇
特种医学   4009篇
外国民族医学   46篇
外科学   14274篇
综合类   750篇
一般理论   100篇
预防医学   6969篇
眼科学   1658篇
药学   6599篇
中国医学   204篇
肿瘤学   6558篇
  2023年   385篇
  2022年   845篇
  2021年   1886篇
  2020年   1168篇
  2019年   1778篇
  2018年   2171篇
  2017年   1508篇
  2016年   1656篇
  2015年   1975篇
  2014年   2654篇
  2013年   4095篇
  2012年   5592篇
  2011年   5872篇
  2010年   3808篇
  2009年   3376篇
  2008年   5206篇
  2007年   5442篇
  2006年   5267篇
  2005年   5025篇
  2004年   4878篇
  2003年   4510篇
  2002年   4369篇
  2001年   2431篇
  2000年   2393篇
  1999年   2211篇
  1998年   1251篇
  1997年   1022篇
  1996年   858篇
  1995年   884篇
  1994年   732篇
  1993年   771篇
  1992年   1544篇
  1991年   1506篇
  1990年   1424篇
  1989年   1394篇
  1988年   1164篇
  1987年   1159篇
  1986年   1102篇
  1985年   1029篇
  1984年   777篇
  1983年   737篇
  1982年   541篇
  1981年   516篇
  1980年   443篇
  1979年   660篇
  1978年   411篇
  1977年   383篇
  1975年   397篇
  1974年   437篇
  1973年   365篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
3.
4.
5.
6.
Advancing nanomedicines from concept to clinic requires integration of new science with traditional pharmaceutical development. The medical and commercial success of nanomedicines is greatly facilitated when those charged with developing nanomedicines are cognizant of the unique opportunities and technical challenges that these products present. These individuals must also be knowledgeable about the processes of clinical and product development, including regulatory considerations, to maximize the odds for successful product registration. This article outlines these topics with a goal to accelerate the combination of academic innovation with collaborative industrial scientists who understand pharmaceutical development and regulatory approval requirements—only together can they realize the full potential of nanomedicines for patients.  相似文献   
7.

Cerebellar mutism syndrome (CMS) occurs in one out of four children after posterior fossa tumor surgery, with open questions regarding risk factors, pathophysiology, and prevention strategies. Because of similarities between several cerebellar syndromes, a common pathophysiology with damage to the dentato-thalamo-cortical and dentato-rubro-olivary pathways has been proposed. Hypertrophic olivary degeneration (HOD) is an imaging correlate of cerebellar injury observed for instance in stroke patients. Aim of this study was to investigate whether the occurrence and severity of CMS correlates with the extent of damage to the relevant anatomical structures and whether HOD is a time-dependent postoperative neuroimaging correlate of CMS. We performed a retrospective single center study of CMS patients compared with matched non-CMS controls. CMS occurred in 10 children (13% of the overall cohort) with a median age of 8 years. Dentate nucleus (DN) injury significantly correlated with CMS, and superior cerebellar peduncle (SCP) injury was associated by tendency. HOD was observed as a dynamic neuroimaging phenomenon in the postoperative course and its presence significantly correlated with CMS and DN injury. Children who later developed HOD had an earlier onset and tended to have longer persistence of CMS. These findings can guide surgical measures to protect the DN and SCP during posterior fossa tumor resections and to avoid a high damage burden (i.e., bilateral damage). Development of intraoperative neuromonitoring of the cerebellar efferent pathways as well as improved preoperative risk stratification could help to establish a patient-specific strategy with optimal balance between degree of resection and functional integrity.

  相似文献   
8.
9.
Clinical Oral Investigations - The aim of this study was the analysis of WNT10A variants in seven families of probands with various forms of tooth agenesis and self-reported family history of...  相似文献   
10.
The aim of this study was to analyse the effect of body mass index (BMI), both low and high values, on the perioperative complication rate in patients with oral squamous cell carcinoma (OSCC). The medical records of 259 patients operated between 2014 and 2017 for OSCC were reviewed. Univariate and multivariate analyses were performed. Sixty of the 259 patients developed 87 complications. Low or high BMI was not associated with the perioperative complication rate. A longer operating time and increased blood loss were associated with a higher perioperative complication rate and higher Clavien–Dindo grade. Low BMI, American Society of Anesthesiologists score 2 and 3, a longer operating time, and increased blood loss were associated with a longer hospital stay. Low BMI was associated with a longer hospital stay. Neither low nor high BMI was associated with the perioperative complication rate. A longer operating time and increased blood loss were associated with a higher perioperative complication rate and higher Clavien–Dindo grade.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号